Legacy AI grade · Sources dated 2026-06-01. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow

Procyanidin B-2 (Apple Polyphenol) for Hair Loss Telogen

Verdict: Unverified for telogen effluvium: no direct evidence

There is no clinical evidence that procyanidin B-2 (apple polyphenol) treats telogen effluvium. Every human trial to date studied male-pattern hair loss, not this condition, so its effectiveness for telogen effluvium remains unproven.

U ⚫ U Unverified Insufficient Evidence

🔬Why this grade7-layer evidence engine

This pair earns an Unverified rating because not a single study has tested procyanidin B-2 in telogen effluvium patients. The only human data are two small, double-blind trials (PMID 11406858, n=29; PMID 11194183, n=29) of 1% topical procyanidin B-2 in men with androgenetic alopecia. Both reported modest hair-count gains, but they were run by one research group, funded by the apple-polyphenol supplier, and judged low quality. Applying them to telogen effluvium is off-label extrapolation, not proof.

The only link to telogen biology is a laboratory study (PMID 11841365) showing procyanidin B-2 down-regulates telogen-specific PKC isozymes and speeds the telogen-to-anagen shift in mice. That is a plausible mechanism, but a preclinical signal in mice cannot establish a clinical effect in people.

Authorities offer no support either. The US FDA recognizes apple polyphenol extract only as a safe food ingredient, with no drug or hair-growth approval, and the EU EFSA concluded a cause-and-effect relationship has not been established for proanthocyanidins. Mayo Clinic, Cleveland Clinic, Harvard, and the AAD never address it; the AAD notes telogen effluvium hair usually regrows once the trigger is resolved, making any benefit hard to distinguish from natural recovery.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.38
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
85%
Highly consistent evidence
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.50
Against Mixed Supports
▸View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.376
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — D 級條件未達 (需 E1-E3 negative;實際 E6)
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent (Takahashi et al.)
PMID: 11406858 2001 RCT (double-blind) n = 29
Finding: Treatment vs placebo: 78.9% vs 30.0% showed increased mean hair diameter (p<0.02); hair count change +3.67±4.09 vs −2.54±4.00 hairs/0.25 cm² (p<0.001). Population was male androgenetic alopecia (AGA), NOT telogen effluvium.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.21 hairs/0.25 cm² vs placebo
View on PubMed
Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent (Takahashi et al.)
PMID: 11194183 2000 RCT (double-blind) n = 29
Finding: Total hair increase: +6.68±5.53 (treatment) vs +0.08±4.56 (placebo), p<0.005; terminal hair increase: +1.99±2.58 vs −0.82±3.40, p<0.02. Same Kyowa Hakko group; population again male AGA, NOT telogen effluvium.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.60 hairs/0.25 cm² vs placebo
View on PubMed
Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study (Kamimura & Takahashi)
PMID: 11841365 2002 Other
Finding: Procyanidin B-2 down-regulates PKC isozymes expressed in a telogen-specific manner and accelerates telogen→anagen transition in shaved C3H mouse dorsal skin. Mechanistically relevant to TE but no human TE data.
🟠 Limited quality ⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Apple polyphenol extract (Applephenon) is generally recognized as safe (GRAS) under the intended conditions of use as a food ingredient source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of proanthocyanidins from various sources and the maintenance of normal blood pressure / maintenance of normal blood flow / protection of body lipids from oxidative damage / maintenance of normal vascular function source↗
L4d TW TFDA / 衛福部
Neutral
本署公告之健康食品保健功效項目共十三項:護肝(針對化學性肝損傷)、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。食品(含一般食品及健康食品)之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形,亦不得涉及醫療效能。 source↗
L5e Specialty Society (condition-mapped)
Not addressed
In most cases, the hair grows back once the cause of the hair loss has been addressed. source↗
✓PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hair-loss-telogen-INT-procyanidin-b-2-001 繁體中文版 →